Drug intelligence / Profile preview

Rosova+

Development stage
Preclinical
Lead developer
Indication Bioscience
Modality
Small Molecules
Administration
Oral
01

Overview

Rosova+ is an investigational oral fixed-dose combination small-molecule candidate from Indication Biosciences in the Statin+ platform for hypercholesterolemia, statin intolerance, and cardiovascular disease. It is described as a rosuvastatin-based combination that pairs rosuvastatin with an undisclosed complementary FDA-approved small molecule. Its intended pharmacology is lipid lowering driven by the established statin mechanism, principally inhibition of **3-hydroxy-3-methylglutaryl-coenzyme A reductase**, with the second component intended to improve tolerability and or therapeutic performance, although the partner molecule and its precise target biology have not been publicly disclosed. The company lists the program as preclinical.

Brand names
Rosova+
Other names
Rosova
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on Rosova+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosova+.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call